VMP 28789211000001106

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Apremilast 30mg tablets
BNF code 1001030AAAAAAAA
Virtual Therapeutic Moiety Apremilast
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Apremilast
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 30.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Otezla 30mg tablets (Amgen Ltd)
Virtual Medicinal Product Packs
Apremilast 30mg tablets 19 tablet
Apremilast 30mg tablets 56 tablet

dm+d data retrieved from TRUD: release NHSBSA_10.2.0_20201019000001, imported on 19th October 2020 at 05:19:44.